Estimates of effects, ranking, and certainty of evidence for different treatment options vs placebo
Everolimus + SSA (1 RCT; 39 participants)
Estimates of effects, ranking, and certainty of evidence for… probably leads to higher everolimus + SSA (2 RCTs; 589 participants) compared with placebo (moderate certainty).
1 finding from 1 review
- Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta‐analysis 2021 · Cochrane Headline outcomes onlyOR 2.89 [1.61, 5.19]2 studies · 589 participantsModerate